IP Library › Granted Patent US 11,117,896
Granted Patent B2
US 11,117,896 · App. 16/660,682 · Granted Sep 14, 2021

Processes for preparing a diazabicyclooctane compound

Inventors: Takao Abe (Kanagawa, JP); Takeshi Furuuchi (Kanagawa, JP); Yoshiaki Sakamaki (Kanagawa, JP); Seiichi Inamura (Kanagawa, JP); Akihiro Morinaka (Kanagawa, JP)
Assignee: MEIJI SEIKA PHARMA CO., LTD.
C07D471/08A61K31/407A61K31/4162A61K31/427A61K31/43A61K31/437A61K31/439A61K31/444A61K31/4545A61K31/5377A61K31/545A61K31/546A61K45/06C07D211/60C07F7/0812Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,117,896
App. No.
16/660,682
Granted
Sep 14, 2021
Kind
B2
Abstract

A process for preparing a diazabicyclooctane compound represented by the following formula (I): wherein A represents RcO—; B represents NH or NC 1-6 alkyl; C represents a benzyl group; Rc represents a C 1-6 alkyl group; A is substituted with one substituent Fn1, wherein Fn1 represents an azetidine group; the process including: (a) silylating the compound represented by the following formula (IV-c): wherein in the formula (IV-c), OBn represents benzyloxy, and (b) carrying out an intramolecular urea formation reaction.

Claims (9)

1. A process for preparing (2S,5R)-N-(2-aminoethoxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide represented by the following formula (III-059):

which comprises:

removing the benzyl of the benzyloxy at the 6-position of a compound represented by the following formula (IIa-Boc-059):

wherein in the formula (IIa-Boc-059), Boc represents tert-butoxycarbonyl, and OBn represents benzyloxy,

in the presence of palladium-carbon under a hydrogen atmosphere to prepare a compound represented by the following formula (IIb-Boc-059):

wherein in the formula (IIb-Boc-059), Boc represents tert-butoxycarbonyl, sulfating the hydroxyl group at the 6-position of the formula (IIb-Boc-059) with a sulfur trioxide-pyridine complex in the presence of pyridine, 2-picoline or 2,6-lutidine to prepare a compound represented by the following formula (III-Boc-059):

wherein in the formula (III-Boc-059), Boc represents tert-butoxycarbonyl, and M represents H, pyridinium, sodium or tetrabutylammonium, and deprotecting the tert-butoxycarbonyl group with an acid selected from the group consisting of hydrochloric acid, sulfuric acid, methanesulfonic acid, trifluoroacetic acid and tetrafluoroboric acid.

2. The process of claim 1 , wherein the sulfating of the hydroxyl group at the 6-position of the formula (IIb-Boc-059) with the sulfur trioxide-pyridine complex is performed in the presence of 2-picoline or 2,6-lutidine.

3. The process of claim 1 , wherein in the formula (III-Boc-059), M represents pyridinium, sodium or tetrabutylammonium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: ABE, TAKAO; FURUUCHI, TAKESHI; SAKAMAKI, YOSHIAKI; INAMURA, SEIICHI; MORINAKA, AKIHIRO
To: MEIJI SEIKA PHARMA CO., LTD.
Reel/Frame 050795/0838 →
Priority Claims (1)
JP 2012-122603 · May 30, 2012 · national
Continuity (5)
Division 15973861 · May 8, 2018
Division 15583238 · May 1, 2017
Division 14872988 · Oct 1, 2015
Division 14404288
Related Publication 20200048253A1 · Feb 13, 2020